PET/CT: More than the sum of two established imaging modalities?

European Journal of Radiology

Volumn 73, Issue 3, 2010, Pages 449-451

  Kletter, K ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CLINICAL RESEARCH; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; EDITORIAL; IMAGE QUALITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

CONTRAST MEDIA; DIFFUSION OF INNOVATION; FLUORODEOXYGLUCOSE F18; FORECASTING; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77949540745     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2009.12.020     Document Type: Editorial

References (16)

1. Jaroff L. Time Mag December 4 (2000)
2. Schwaiger M., Ziegler S.I., and Nekolla S.G. PET/CT challenge for the non invasive diagnosis of coronary artery disease. Eur J Radiol 73 (2010) 494-503
3. Czernin J., Benz M.R., and Allen-Auerbach M.S. PET/CT imaging: the incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination. Eur J Radiol 73 (2010) 470-480
4. Lonsdale M.N., and Beyer T. Dual-modality PET/CT instrumentation-today and tomorrow. Eur J Radiol 73 (2010) 452-460
5. Conti M. State of the art and challenges of time-of-flight PET. Phys Med 25 1 (2009) 1-11
6. Pichler B.J., Wehrl H.F., and Judenhofer M.S. Latest advances in molecular imaging instrumentation. J Nucl Med 49 Suppl. 2 (2008) 5S-23S
7. Achenbach S., Anders K., and Kalender W.A. Dual source cardiac computed tomography: image quality and dose considerations. Eur Radiol 18 (2008) 1188-1198
8. Brix G., Lechel U., Glatting G., et al. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. J Nucl Med 46 4 (2005) 608-613
9. Wadsak W., and Mitterhauser M. Basics and principles of radiopharmaceuticals for PET/CT. Eur J Radiol 73 (2010) 461-469
10. Dudczak R., and Traub-Weidinger T. PET and PET/CT in endocrine tumours. Eur J Radiol 73 (2010) 481-493
11. Langström B., Grahnen A., Honoré P.H., et al. The risk of exaggerated risk aversion-a life and death struggle of molecular imaging. Eur J Nucl Med Mol Imaging 36 (2009) 1693-1694
12. Czernin J., Allen-Auerbach M., and Schelbert H.R. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nucl Med 48 Suppl. 1 (2007) 78S-88S
13. Kitajima K., Murakami K., Yamasaki E., et al. Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT. Eur J Nucl Med Mol Imaging 36 9 (2009) 1388-1396
14. Fueger B.J., Yeom K., Czernin J., et al. Comparison of CT, PET, and PET/CT for staging of patients with indolent non-Hodgkin's lymphoma. Mol Imaging Biol 11 4 (2009) 269-274
15. Buck A.K., Nekolla S., Ziegler S., et al. SPECT/CT. J Nucl Med 49 (2008) 1305-1319
16. Judenhofer M.S., Wehrl H.F., Newport D.F., et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med 14 4 (2008) 459-465